These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9764912)

  • 1. Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries.
    Bibollet-Ruche F; Peeters M; Mboup S; Ekaza E; Gandji R; Torimiro J; Mpoudi EN; Amblard J; Dibanga G; Saidou M; Esu-Williams E; Vanden Haesevelde M; Saman E; Delaporte E
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1281-5. PubMed ID: 9764912
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of non-B HIV type 1 subtypes from Africa in Spain.
    Ortiz M; Muñoz L; Bernal A; Rodriguez A; Zorraquino A; Vadillo J; Salas A; Moreno A; García-Sáiz A
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1967-71. PubMed ID: 11153079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping.
    Agwale SM; Robbins KE; Odama L; Saekhou A; Zeh C; Edubio A; Njoku OM; Sani-Gwarzo N; Gboun MF; Gao F; Reitz M; Hone D; Folks TM; Pieniazek D; Wambebe C; Kalish ML
    J Clin Microbiol; 2001 Jun; 39(6):2110-4. PubMed ID: 11376043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotyping and genotyping of HIV-1 infection in residents of Khayelitsha, Cape Town, South Africa.
    Jacobs GB; de Beer C; Fincham JE; Adams V; Dhansay MA; van Rensburg EJ; Engelbrecht S
    J Med Virol; 2006 Dec; 78(12):1529-36. PubMed ID: 17063507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.
    Zouhair S; Roussin-Bretagne S; Moreau A; Brunet S; Laperche S; Maniez M; Barin F; Harzic M
    J Clin Microbiol; 2006 Feb; 44(2):662-5. PubMed ID: 16455942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States.
    Sullivan PS; Do AN; Ellenberger D; Pau CP; Paul S; Robbins K; Kalish M; Storck C; Schable CA; Wise H; Tetteh C; Jones JL; McFarland J; Yang C; Lal RB; Ward JW
    J Infect Dis; 2000 Feb; 181(2):463-9. PubMed ID: 10669327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular screening for HIV-1 group N and simian immunodeficiency virus cpz-like virus infections in Cameroon.
    Fonjungo PN; Dash BC; Mpoudi EN; Torimiro JN; Alemnji GA; Eno LT; Nkengasong J; Rayfield M; Folks TM; Pieniazek D; Lal RB
    AIDS; 2000 Apr; 14(6):750-2. PubMed ID: 10807202
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G.
    Ellenberger DL; Pieniazek D; Nkengasong J; Luo CC; Devare S; Maurice C; Janini M; Ramos A; Fridlund C; Hu DJ; Coulibaly IM; Ekpini E; Wiktor SZ; Greenberg AE; Schochetman G; Rayfield MA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):3-9. PubMed ID: 10024047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence of gp41env immunodominant region of HIV type 1 group O from west central Africa.
    Brennan CA; Hackett J; Zekeng L; Lund JK; Vallari AS; Hickman RK; Gürtler L; Kaptue L; Von Overbeck J; Hampl H; Devare SG
    AIDS Res Hum Retroviruses; 1997 Jul; 13(10):901-4. PubMed ID: 9197385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O.
    Yang C; Gao F; Fonjungo PN; Zekeng L; van der Groen G; Pieniazek D; Schable C; Lal RB
    AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1075-81. PubMed ID: 10933623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon.
    Fonjungo PN; Mpoudi EN; Torimiro JN; Alemnji GA; Eno LT; Nkengasong JN; Gao F; Rayfield M; Folks TM; Pieniazek D; Lal RB
    AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1319-24. PubMed ID: 10957729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.
    Sabatier JM; Mabrouk K; Moulard M; Rochat H; Van Rietschoten J; Fenouillet E
    Virology; 1996 Sep; 223(2):406-8. PubMed ID: 8806580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogeny of HIV type 1 group O isolates based on env gene sequences.
    Mas A; Quiñones-Mateu ME; Domingo E; Soriano V
    AIDS Res Hum Retroviruses; 1999 May; 15(8):769-73. PubMed ID: 10357472
    [No Abstract]   [Full Text] [Related]  

  • 15. A 100-amino acid truncation in the cytoplasmic tail of glycoprotein 41 in the reference HIV type 1 strain RF.
    Jones DR; Suzuki K; Piller SC
    AIDS Res Hum Retroviruses; 2002 May; 18(7):513-7. PubMed ID: 12015905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
    Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: high polymorphism rates in the HR1 and HR2 gp41 and presence of primary resistance-related mutations in HIV type 1 circulating in Brazil: possible impact on enfuvirtide efficacy.
    Teixeira C; de Sá-Filho D; Alkmim W; Janini LM; Diaz RS; Komninakis S
    AIDS Res Hum Retroviruses; 2010 Mar; 26(3):307-11. PubMed ID: 20334566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enfuvirtide is active against HIV type 1 group O.
    Poveda E; Barreiro P; Rodés B; Soriano V
    AIDS Res Hum Retroviruses; 2005 Jun; 21(6):583-5. PubMed ID: 15989465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections.
    Zeh C; Pieniazek D; Agwale SM; Robbins KE; Odama L; Sani-Gwarzo N; Gboun MS; Inyang US; Folks TM; Wambebe C; Kalish ML
    AIDS Res Hum Retroviruses; 2005 Jan; 21(1):17-27. PubMed ID: 15665641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.